AQR Arbitrage’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

AQR Arbitrage’s Portfolio EBACW Stock Details EBACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,666	Closed	-$3.67K	–	1214
2022 Q4	$3.67K	Hold	14,666	–	–	﹤0.01%	1069
2022 Q3	$1K	Hold	14,666	–	–	﹤0.01%	1430
2022 Q2	$2K	Hold	14,666	–	–	﹤0.01%	1469
2022 Q1	$3K	Hold	14,666	–	–	﹤0.01%	1354
2021 Q4	$142K	Hold	14,666	–	–	﹤0.01%	1162
2021 Q3	$9K	Hold	14,666	–	–	﹤0.01%	1156
2021 Q2	$14K	Buy	+14,666	New	+$13.6K	﹤0.01%	1096

AQR Arbitrage's EBACW Position: Q1 2023 in Review

AQR Arbitrage sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 14,666 shares — an estimated $3.67K sold.

AQR Arbitrage first reported a position in EBACW in Q2 2021 and held it in 7 quarters. The position peaked at $142K in Q4 2021. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

AQR Arbitrage reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
AQR Arbitrage sold 14,666 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $3.67K.
AQR Arbitrage first reported a position in European Biotech Acquisition Corp. Warrant in Q2 2021 and held it in 7 quarters.
AQR Arbitrage's European Biotech Acquisition Corp. Warrant position peaked at $142K in Q4 2021.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on AQR Arbitrage's 13F filing for Q1 2023, filed 15 May 2023.